Search
Calidi Biotherapeutics Inc
CLDIAdd to Watchlist
1.640USD
+0.177+11.87%
Close 07-31 16:00（ET）Quotes delayed by 15 min
11.33MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31No earnings forecast score is currently available for Calidi Biotherapeutics Inc. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 10.00, with a high of 10.00 and a low of 10.00.
Analyst Rating
Based on
1
analysts
Strong Buy
Current Rating
10.000
Target Price
+4247.83%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Calidi Biotherapeutics Inc
CLDI
1
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Calidi Biotherapeutics Inc's price target?
Analysts forecast that Calidi Biotherapeutics Inc's price target is USD 10.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 10.00.
What is the analyst rating for Calidi Biotherapeutics Inc?
Based on the ratings of Calidi Biotherapeutics Inc's stock from 1 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.